Work

Trends in estrogen administration routes and associations with selected cardiometabolic conditions among US women aged 40 years and older: MEPS, 2017–2023

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Estrogen administration routes are clinically relevant in women with cardiometabolic diseases (CMDs). We examined associations between CMDs and recorded estrogen administration route. Methods We analyzed women aged ≥40 years with oral or transdermal estrogen use in the 2017–2023 Medical Expenditure Panel Survey. CMDs comprised hypertension, diabetes, and hypercholesterolemia. Survey-weighted logistic models adjusted for age, year, race/ethnicity, insurance, income, education, region, and marital status. Annual route distributions were also evaluated. Results The sample included 1,148 person-years from 724 women. Transdermal use accounted for 29.3% overall and 32.8%, 31.6%, and 21.1% among observations with zero, one, and at least two CMDs, respectively. Adjusted odds ratios were 0.95 (95% CI, 0.62–1.45) for any CMD and 0.77 (95% CI, 0.44–1.34) for at least two CMDs compared with none. Annual transdermal use increased from 19.7% in 2017 to 38.3% in 2023; the adjusted odds ratio per year was 1.14 (95% CI, 1.05–1.25). Conclusion Transdermal estrogen represented an increasing share of use. Adjusted associations with CMDs were imprecise. Further research should examine how disease control and patient preferences relate to route selection.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7237224707
FWCI:
Cites: 25
Cited by:
Related to: 10
Parts: 2